NASDAQ
Cosmo Pharmaceuticals N.V. (CMOPF) has a free cash flow growth of -726.96% as of Friday, May 29, 2026. This represents a 874.92% decrease compared to its 12-month average of 93.81%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.